Results 11 to 20 of about 132,279 (295)

Supervised chemical graph mining improves drug-induced liver injury prediction

open access: yesiScience, 2022
Summary Drug-induced liver injury (DILI) is the main cause of drug failure in clinical trials. The characterization of toxic compounds in terms of chemical structure is important because compounds can be metabolized to toxic substances in the liver ...
Sangsoo Lim   +5 more
semanticscholar   +2 more sources

A General Overview of Mesenchymal Stem Cell Therapies in Drug- and Chemical-Induced Liver Injury Models [PDF]

open access: yesGazi Medical Journal
Liver injury is commonly seen in the population depending on the drug and chemical usage. Different groups of drugs and chemicals lead to different pathogeneses in the liver, such as necrosis, fibrosis, or inflammation.
Müşerref Şeyma Ceyhan   +2 more
doaj   +2 more sources

Chemistry-Based Modeling on Phenotype-Based Drug-Induced Liver Injury Annotation: From Public to Proprietary Data

open access: yesChemical Research in Toxicology, 2023
Drug-induced liver injury (DILI) is an important safety concern and a major reason to remove a drug from the market. Advancements in recent machine learning methods have led to a wide range of in silico models for DILI predictive methods based on ...
M. Moein   +8 more
semanticscholar   +2 more sources

Improved Detection of Drug-Induced Liver Injury by Integrating Predicted In Vivo and In Vitro Data [PDF]

open access: yesChemical Research in Toxicology
Drug-induced liver injury (DILI) has been a significant challenge in drug discovery, often leading to clinical trial failures and necessitating drug withdrawals.
Srijit Seal   +6 more
semanticscholar   +7 more sources

Vanishing bile duct syndrome in drug-induced liver injury: clinical and pathologic perspectives

open access: yesExploration of Medicine
Vanishing bile duct syndrome (VBDS) is a rare condition, representing approximately 0.5% of small bile duct diseases, characterized by progressive destruction of intrahepatic bile ducts, leading to ductopenia.
Sugunah Sallapan   +4 more
semanticscholar   +2 more sources

Assessment of Drug-Induced Liver Injury through Cell Morphology and Gene Expression Analysis

open access: yesChemical Research in Toxicology, 2023
Drug-induced liver injury (DILI) is a significant concern in drug development, often leading to drug withdrawal. Although many studies aim to identify biomarkers and gene/pathway signatures related to liver toxicity and aim to predict DILI compounds ...
Vanille Lejal   +3 more
semanticscholar   +2 more sources

Exploring Avenues of Predicting Drug-Induced Liver Injury. [PDF]

open access: yesChem Res Toxicol
Drug induced liver injury prediction is advancing through mechanistic modeling, patient-derived systems, and emerging immune-based biomarkers. Integrating these approaches improves drug safety and reduces development failures.
Liyanarachchi DP.
europepmc   +2 more sources

dialogi: Utilising NLP With Chemical and Disease Similarities to Drive the Identification of Drug-Induced Liver Injury Literature

open access: yesbioRxiv, 2022
Drug-Induced Liver Injury (DILI), despite its low occurrence rate, can cause severe side effects or even lead to death. Thus, it is one of the leading causes for terminating the development of new, and restricting the use of already-circulating, drugs ...
Nicholas M. Katritsis   +7 more
semanticscholar   +1 more source

The protective effect and crucial biological pathways analysis of Trametes lactinea mycelium polysaccharides on acute alcoholic liver injury in mice based on transcriptomics and metabonomics

open access: yesFood Science and Human Wellness, 2021
Trametes lactinea mycelia polysaccharides (TLMPS) have a wide range of bioactivities. The potential mechanisms of action of TLMPS against acute alcohol-induced liver injury in vivo were investigated by analyzing the physical and chemical properties of ...
Jinbin Hao   +5 more
doaj   +1 more source

Ashwagandha‐induced liver injury: A case series from Iceland and the US Drug‐Induced Liver Injury Network

open access: yes, 2020
Background & aims: Ashwagandha (Withania somnifera) is widely used in Indian Ayurvedic medicine. Several dietary supplements containing ashwagandha are marketed in the US and Europe, but only one case of drug-induced liver injury (DILI) due to ...
Marwan Ghabril   +15 more
core   +2 more sources

Home - About - Disclaimer - Privacy